Skip to main content

Markers of Inflammation

  • Protocol
  • First Online:
Immunotoxicity Testing

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 598))

Abstract

Inflammation is a complex and necessary component of an organism’s response to biological, chemical or physical stimuli. In the acute phase, cells of the immune system migrate to the site of injury in a carefully orchestrated sequence of events that is mediated by cytokines and acute phase proteins. Depending upon the degree of injury, this acute phase may be sufficient to resolve the damage and initiate healing. Persistent inflammation as a result of prolonged exposure to stimulus or an inappropriate reaction to self molecules can lead to the chronic phase, in which tissue damage and fibrosis can occur. Chronic inflammation is reported to contribute to numerous diseases including allergy, arthritis, asthma, atherosclerosis, autoimmune diseases, diabetes, and cancer, and to conditions of aging. Hematology and clinical chemistry data from standard toxicology studies can provide an initial indication of the presence and sometimes location of inflammation in the absence of specific data on the immune tissues. These data may suggest more specific immune function assays are necessary to determine the existence or mechanism(s) of ­immunomodulation. Although changes in hematology dynamics, acute phase proteins, complement factors and cytokines are common to virtually all inflammatory conditions and can be measured by a variety of techniques, individual biomarkers have yet to be strongly associated with specific pathologic events. The specific profile in a given inflammatory condition is dependent upon species, mechanisms, severity, chronicity, and capacity of the immune system to respond and adapt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–455

    Article  CAS  PubMed  Google Scholar 

  2. NIA workshop on inflammation, inflammatory mediators, and aging. Sept. 1–2, 2004. Sponsored by National Institute on Aging, National Institutes of Health, Department of Health and Human Services. Workshop summary. Available at http://www.nia.nih.gov/NR/rdonlyres/A8B847EC-8E2B-418D-AD39-62D56E8CEAB2/2083/NIAWorkshoponInflammationMtgRpt61805_Ed.pdf. Accessed 9 Jan 2009

  3. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  CAS  PubMed  Google Scholar 

  4. Alegre J, Jufresa J, Segura R et al (2002) Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions. Eur Respir J 19:320–325

    Article  CAS  PubMed  Google Scholar 

  5. Buttarello M, Plebani M (2008) Automated blood cell counts: state of the art. Am J Clin Pathol 130:104–116

    Article  PubMed  Google Scholar 

  6. Grattan CE, Dawn G, Gibbs S, Francis DM (2003) Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 33:337–341

    Article  CAS  PubMed  Google Scholar 

  7. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME (2003) Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 111:227–242

    Article  CAS  PubMed  Google Scholar 

  8. Latimer KS, Mahaffey EA, Prasse KW (eds) (2003) Duncan & Prasse’s veterinary laboratory medicine: clinical pathology, 4th edn. Iowa State Press, Ames, IA

    Google Scholar 

  9. Weyrich AS, Zimmerman GA (2004) Platelets: signaling cells in the immune continuum. Trends Immunol 25:489–495

    Article  CAS  PubMed  Google Scholar 

  10. Kosone T, Takagi H, Horiguchi N et al (2007) Hepatocyte growth factor accelerates thrombopoiesis in transgenic mice. Lab Invest 87:284–291

    Article  CAS  PubMed  Google Scholar 

  11. González-Villalva A, Fortoul TI, Avila-Costa MR et al (2006) Thrombocytosis induced in mice after subacute and subchronic V2O5 inhalation. Toxicol Ind Health 22:113–116

    Article  PubMed  Google Scholar 

  12. Means RT, Krantz SB (1992) Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639–1647

    PubMed  Google Scholar 

  13. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352:1012–1023

    Article  Google Scholar 

  14. Zarychanski R, Houston DS (2008) Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ 179:333–337

    PubMed  Google Scholar 

  15. Evans EW (2008) Clinical pathology as crucial insight into immunotoxicity testing. In: Bussiere JL, Herzyk D (eds) Immunotoxicology strategies for pharmaceutical safety assessment. Wiley, Hoboken, NJ, pp 13–26

    Google Scholar 

  16. Sell S (2001) Inflammation and wound healing. In: Sell S (ed) Immunology, immunopathology and immunity, 6th edn. ASM press, Washington, DC, pp 33–100

    Google Scholar 

  17. Kelly M, Hwang JM, Kubes P (2007) Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol 120:3–10

    Article  CAS  PubMed  Google Scholar 

  18. Mousa SA (2002) Cell adhesion molecules: potential therapeutic and diagnostic implications. In: Rose NR, Hamilton RG, Detrick B (eds) Manual of clinical laboratory immunology, 6th edn. ASM press, Washington, DC, pp 368–375

    Google Scholar 

  19. Sarada S, Himadri P, Mishra C, Geetail P, Ram MS, Ilavazhagan G (2008) Role of oxidative stress and NFKB in hypoxia-induced pulmonary edema. Exp Biol Med (Maywood) 233:1088–1098

    Article  CAS  Google Scholar 

  20. Bashir MM, Sharma MR, Werth VP (2009) TNF-alpha production in the skin. Arch Dermatol Res 301:87–91

    Article  CAS  PubMed  Google Scholar 

  21. Schmid H, Boucherot A, Yasuda Y et al (2006) Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55:2993–3003

    Article  CAS  PubMed  Google Scholar 

  22. Bachmann MF, Kopf M, Marsland BJ (2006) Chemokines: more than just road signs. Nat Rev Immunol 6:159–164

    Article  CAS  PubMed  Google Scholar 

  23. Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891–928

    Article  CAS  PubMed  Google Scholar 

  24. Abbadie C (2005) Chemokines, chemokine receptors and pain. Trends Immunol 26:529–534

    Article  CAS  PubMed  Google Scholar 

  25. Moser B, Wolf M, Walz A, Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75–84

    Article  CAS  PubMed  Google Scholar 

  26. Poznansky MC, Scadden DT, Luster AD (2002) Chemokine and chemokine receptor analysis. In: Rose NR, Hamilton RG, Detrick B (eds) Manual of clinical laboratory immunology, 6th edn. ASM press, Washington, DC, pp 357–367

    Google Scholar 

  27. Gentry PA (1999) Acute phase proteins. In: Loeb WF, Quimby FW (eds) The clinical chemistry of laboratory animals, 2nd edn. Taylor and Francis, Philadelphia, PA, pp 336–398

    Google Scholar 

  28. Evans EW, Duncan JR (2003) Proteins, lipids and carbohydrates. In: Latimer KS, Mahaffey EA, Prasse KW (eds) Duncan & Prasse’s veterinary laboratory medicine: clinical pathology, 4th edn. Iowa State Press, Ames, IA, pp 162–192

    Google Scholar 

  29. Kushner I, Rzewnicki D, Samols D (2006) What does minor elevation of C-reactive protein signify? Am J Med 119:166e.17–166e.28

    Google Scholar 

  30. Kind CRH, Pepys MB (1984) The role of C-reactive protein (CRP) measurement in clinical practice. Int Med 5:112–151

    Google Scholar 

  31. Acevedo M, Corbalán R, Braun S, Pereira J, Navarrete C, Gonzalez I (2006) C-reactive protein and atrial fibrillation: “evidence for the presence of inflammation in the perpetuation of the arrhythmia”. Int J Cardiol 108:326–331

    Article  PubMed  Google Scholar 

  32. Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK (2002) C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 144:233–238

    Article  CAS  PubMed  Google Scholar 

  33. Nesto R (2004) C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med 21:810–817

    Article  CAS  PubMed  Google Scholar 

  34. Corrado E, Rizzo M, Muratori I, Coppola G, Novo S (2006) Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res 37:1004–1009

    Article  CAS  PubMed  Google Scholar 

  35. Murphy KM, Travers P, Walport M (2007) Janeway’s immunobiology, 7th edn. Garland Science Textbooks, New York

    Google Scholar 

  36. Giclas P (2002) Choosing complement tests: differentiating between hereditary and acquired deficiency. In: Rose NR, Hamilton RG, Detrick B (eds) Manual of clinical laboratory immunology, 6th edn. ASM press, Washington, DC, pp 111–116

    Google Scholar 

  37. Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM (2005) Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett 97:171–179

    Article  CAS  PubMed  Google Scholar 

  38. Altieri D (2001) Interface between inflammation and coagulation. In: Ley K (ed) Physiology of inflammation. Oxford University Press, Oxford, England, pp 402–422

    Google Scholar 

  39. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28:184–192

    Article  CAS  PubMed  Google Scholar 

  40. Sitrin RG, Pan PM, Srikanth S, Todd RF 3rd (1998) Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol 161:1462–1470

    CAS  PubMed  Google Scholar 

  41. Paraskevas KI, Baker DM, Vrentzos GE, Mikhailidis DP (2008) The role of fibrinogen and fibrinolysis in peripheral arterial disease. Thromb Res 122:1–12

    Article  CAS  PubMed  Google Scholar 

  42. Shen Z, Want EJ, Chen W et al (2006) Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting. J Proteome Res 5:3154–3160

    Article  CAS  PubMed  Google Scholar 

  43. He QY, Yang H, Wong BC, Chiu JF (2008) Serological proteomics of gastritis: degradation of apolipoprotein A-1 and alpha-1-antitrypsin is a common response to inflammation irrespective of Helicobacter pylori infection. Dig Dis Sci 53:3112–3118

    Article  CAS  PubMed  Google Scholar 

  44. Cho WC, Yip TT, Chung WS, Leung AW, Cheng CH, Yue KK (2006) Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats. J Cell Biochem 99:256–268

    Article  CAS  PubMed  Google Scholar 

  45. Hanas JS, Hocker JR, Cheung JY et al (2008) Biomarker identification in human pancreatic cancer sera. Pancreas 36:61–69

    Article  CAS  PubMed  Google Scholar 

  46. Kristiansson MH, Bhat VB, Babu IR, Wishnok JS, Tannenbaum SR (2007) Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice. J Proteome Res 6:1735–1744

    Article  CAS  PubMed  Google Scholar 

  47. Lull ME, Carkaci-Salli N, Freeman WM et al (2008) Plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass. Pediatr Res 63:638–644

    Article  CAS  PubMed  Google Scholar 

  48. Wu J, Kobayashi M, Sousa EA et al (2005) Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics 4:1251–1264

    Article  CAS  PubMed  Google Scholar 

  49. Ezendam J, Staedtler F, Pennings J et al (2004) Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats. Environ Health Perspect 112:782–791

    CAS  PubMed  Google Scholar 

  50. Tabibiazar R, Wagner RA, Deng A, Tsao PS, Quertermous T (2006) Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice. Physiol Genomics 25:194–202

    Article  CAS  PubMed  Google Scholar 

  51. Parikh SV, de Lemos JA (2006) Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice. Am J Med Sci 332:186–197

    Article  PubMed  Google Scholar 

  52. Mehra MR, Feller E, Rosenberg S (2006) The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside. Nat Clin Pract Cardiovasc Med 3:136–143

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Germolec, D.R., Frawley, R.P., Evans, E. (2010). Markers of Inflammation. In: Dietert, R. (eds) Immunotoxicity Testing. Methods in Molecular Biology™, vol 598. Humana Press. https://doi.org/10.1007/978-1-60761-401-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-401-2_5

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-400-5

  • Online ISBN: 978-1-60761-401-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics